Peter Giannousis

Title: The Innovative Contributions of Peter Giannousis

Introduction

Peter Giannousis is a notable inventor based in Mountain View, CA. He has made significant contributions to the field of pharmaceuticals and biotechnology, holding a total of 7 patents. His work focuses on developing innovative solutions for treating various health disorders.

Latest Patents

Among his latest patents is a groundbreaking invention related to polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide. This patent discloses polymorphic and amorphous forms of anhydrate, hydrate, and solvates of the compound, along with methods for using these compositions to treat or suppress oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases, and diseases of aging. Another significant patent involves methods for enriching alpha-tocotrienol from mixed tocol compositions, providing methods for creating an alpha-tocotrienol enriched tocol mixture from plant-derived materials.

Career Highlights

Peter has worked with several prominent companies in the biotechnology sector, including PTC Therapeutics, Inc. and Bioelectron Technology Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Peter has collaborated with notable professionals in his field, including Paul Mollard and Shazad Suchit. These collaborations have further enhanced his research and development efforts.

Conclusion

Peter Giannousis is a distinguished inventor whose work has significantly impacted the pharmaceutical industry. His innovative patents and collaborations demonstrate his commitment to advancing medical science and improving health outcomes.